Journals / İstanbul Tıp Fakültesi Dergisi / 2022 / Cilt: 85 - Sayı: 1

EVALUATION OF PTEN AND PI3K/AKT EXPRESSIONS IN STANOZOLOL-TREATED RAT KIDNEYS

STANOZOLOL UYGULANAN SIÇAN BÖBREĞİNDE PTEN VE PI3K/AKT EKSPRESYONLARININ DEĞERLENDİRİLMESİ

Pages
59–66
Publication Date
2022-01-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Exercise performed with AAS usage can be protective on stanozolol-exposed kidneys due to increased levels of PTEN expression and decreased levels of Pi3k and Akt1.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Stanozolol is an anabolic androgenic steroid (AAS) that is widely used by teenagers and athletes in bodybuilding, sports, and athletics.
📊
Key Findings & Data:In this study we investigated the expression of tumor suppressor protein phosphatase and tensin homolog (Pten) and mRNA levels of phosphatidylinositol 4,5-bisphosphate 3 kinase (Pi3k) and the protein kinase B (Akt1) signaling pathway in rat kidneys treated by stanozolol.
💡
Conclusion & Impact:Exercise performed with AAS usage can be protective on stanozolol-exposed kidneys due to increased levels of PTEN expression and decreased levels of Pi3k and Akt1.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Stanozolol · Böbrek · PTEN

Abstract

Objective: Stanozolol is an anabolic androgenic steroid (AAS) that is widely used by teenagers and athletes in bodybuilding, sports, and athletics. The potential effects of stanozolol in kidney functions have not been defined. In this study we investigated the expression of tumor suppressor protein phosphatase and tensin homolog (Pten) and mRNA levels of phosphatidylinositol 4,5-bisphosphate 3 kinase (Pi3k) and the protein kinase B (Akt1) signaling pathway in rat kidneys treated by stanozolol. Materials and Methods: Rats were randomized to 5 groups as control, solvent control, steroid (stanozolol), solvent-exercise, and steroid-exercise. Subcutaneous injection of stanozolol (5 mg/kg) was applied for 28 days and swimming exercise was performed 20 min/day, 5 days/week in exercise groups. Expression of PTEN was evaluated by immunohistochemistry. Also, Pten, Pi3k, and Akt1 mRNA expressions were analyzed via RT-PCR. Results: Mesangial cells and renal tubules in the control, solvent control, and solvent exercise groups showed strong (+++) PTEN reactivity against weak PTEN reactivity in the steroid group. Moderate PTEN reactivity was detected in cells of the steroid exercise group. Pten mRNA expression was significantly decreased, and Pi3k and Akt1 mRNA expression were significantly increased in the steroid group versus other groups (p<0.001). Pten expression showed increase while Pi3k and Akt1 expression showed decrease with exercise treatment (p<0.05). Conclusion: Our findings suggest that AAS usage may inhibit PTEN expression in kidneys, which can be associated with increased Pi3k and Akt1 mRNA levels. Exercise performed with AAS usage can be protective on stanozolol-exposed kidneys due to increased levels of PTEN expression and decreased levels of Pi3k and Akt1.

Özet

Amaç: Stanozolol, gençler ve sporcular tarafından vücut geliştirme, spor ve atletizmde yaygın kullanımı olan bir anabolik androjenik steroiddir (AAS). Stanozololün böbrek fonksiyonlarındaki potansiyel etkileri tanımlanmamıştır. Bu çalışmada, stanozolol ile tedavi edilen sıçan böbreklerinde tümör baskılayıcı protein fosfotaz tensin homolog (Pten), Phosphatidylinositol-3-kinase (Pi3k) ve protein kinaz B (Akt1)’nin mRNA düzeylerinin ekspresyonunu araştırdık. Gereç ve Yöntem: Sıçanlar, kontrol, çözücü kontrol, steroid, çözücü kontrol egzersiz, steroid egzersiz olarak 5 gruba ayrıldı. Yirmi sekiz gün boyunca subkutan stanozolol enjeksiyonu (5 mg/ kg) uygulandı ve egzersiz gruplarındaki hayvanlara 20 dk/gün, 5 gün/hafta yüzme egzersizleri yaptırıldı. PTEN ekspresyonu immünohistokimya ile değerlendirildi. Ayrıca Pten, Pi3k ve Akt1 mRNA ekspresyonları RT-PCR yoluyla analiz edildi. Bulgular: Kontrol, çözücü kontrol ve çözücü kontrol egzersiz gruplarındaki mezanjiyal hücreler ve böbrek tübülleri, steroid grubunda saptanan zayıf PTEN reaktivitesine karşı güçlü (+++) PTEN reaktivitesi gösterdi. Steroid egzersiz grubunun mezanjiyal ve tübül hücrelerinde orta düzeyde PTEN reaktivitesi saptandı. Pten mRNA ekspresyonu, steroid grubunda kontrol ve diğer gruplara göre anlamlı düşüş gösterdi, Pi3k ve Akt1 mRNA ekspresyonu anlamlı olarak arttı (p <0.001). Egzersiz tedavisi ile Pten ekspresyonu artış, Pi3k ve Akt1 ekspresyonu azalma gösterdi (p<0.05). Sonuç: Bulgularımız, AAS kullanımının, artan Pi3k ve Akt1 mRNA seviyeleri ile ilişkili olabilecek böbreklerde PTEN ekspresyonunu inhibe edebileceğini düşündürmektedir. AAS kullanımı ile yapılan egzersiz, PTEN ekspresyon seviyelerinin artması ve Pi3k ve Akt1 seviyelerinin düşmesi nedeniyle stanozolole maruz kalan böbrekler üzerinde koruyucu olabilir.

🔖

Cite This Article

KOTİL, T., SEVİM, Ç., KARA, M. (2022). EVALUATION OF PTEN AND PI3K/AKT EXPRESSIONS IN STANOZOLOL-TREATED RAT KIDNEYS. İstanbul Tıp Fakültesi Dergisi, Cilt: 85 - Sayı: 1, 59–66. https://ajindex.com/articles/373223

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997
  2. 82(2):407-13. [CrossRef] 2. Yesalis CE, Bahrke MS. Anabolic-androgenic steroids and related substances. Curr Sports Med Rep 2002
  3. 1(4):246-52. [CrossRef] 3. Lionikas A, Blizard DA. Diverse effects of stanozolol in C57BL/6J and A/J mouse strains. Eur J Appl Physiol 2008
  4. 103(3):333-41. [CrossRef] 4. Dornelles GL, Bueno A, de Oliveira JS, da Silva AS, França RT, da Silva C, et al. Biochemical and oxidative stress markers in the liver and kidneys of rats submitted to different protocols of anabolic steroids. Molecular And Cellular Biochemistry 2017
  5. 425(1-2):181-9. [CrossRef] 5. Davani-Davari D, Karimzadeh I, Khalili H. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. BMC Nephrology 2019
  6. 20(1):198. [CrossRef] 6. Almukhtar SE, Abbas AA, Muhealdeen DN, Hughson MD. Acute kidney injury associated with androgenic steroids and nutritional supplements in bodybuilders. Clin Kidney J 2015
  7. 8(4):415-9. [CrossRef] 7. Daher EDF, Fernandes PHPD, Meneses GC, Bezerra GF, Ferreira LDSL, Viana GBD, et al. Novel kidney injury biomarkers among anabolic androgenic steroids usersevidence of subclinical kidney disease. Asian J Sports Med 2018
  8. 9(1):e65540. [CrossRef] 8. Juhn M. Popular sports supplements and ergogenic aids. Sports Med 2003
  9. 33(12):921-39. [CrossRef] 9. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 2005
  10. 158(3):167-75. [CrossRef] 10. Yoshida EM, Karim MA, Shaikh JF, Soos JG, Erb SR. At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol. CMAJ 1994
  11. 151(6):791-3. 11. Habscheid W, Abele U, Dahm HH. Schwere Cholestase mit Nierenversagen durch Anabolika bei einem Bodybuilder [Severe cholestasis with kidney failure from anabolic steroids in a body builder]. Dtsch Med Wochenschr 1999
  12. 124(36):1029-32. [CrossRef] 12. Merino García E, Borrego Utiel FJ, Martínez Arcos MÁ, Borrego Hinojosa J, Pérez Del Barrio MP. Kidney damage due to the use of anabolic androgenic steroides and practice of bodybuilding. Nefrologia 2018
  13. 38(1):101-3. [CrossRef] 13. Tabatabaee SM, Elahi R, Savaj S. Bile cast nephropathy due to cholestatic jaundice after using stanozolol in 2 amateur bodybui